-
Bivalirudin
- indication:For treatment of heparin-induced thrombocytopenia
- pharmacologypharmacology:
- mechanism: Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding exosite.
- toxicity:
- absorprion:
- halflife: 25 min (in normal conditions)
- roouteelimination: Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage
- volumedistribution:
- clearance: * 3.4 mL/min/kg [Normal renal function] * 3.4 mL/min/kg [mild renal function] * 2.7 mL/min/kg [moderate renal function] * 2.8 mL/min/kg [severe renal function] * 1 mL/min/kg [Dialysis-dependent patients]